ROBERT ROTENBERG: Open Payments
NPI 1144685207 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 82 payments from 17 companies in 2025. Trend: 2023 $402 · 2024 $1,611 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $256 |
| ABBVIE INC. | 15 | $249 |
| Novo Nordisk Inc | 18 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $199 |
| Exact Sciences Corporation | 4 | $101 |
| Lilly USA, LLC | 6 | $94 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: NURTEC ODT, Kerendia, Ozempic, QULIPTA, VRAYLAR, MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
